Rosacea: Epidemiology, pathogenesis, clinical presentation, and treatment;Rosazea: Epidemiologie, pathogenese, klinik und therapie

Deutsches Arzteblatt

Volumn 104, Issue 24, 2007, Pages

  Lehmann, Percy Mario ^a  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Chronic disease; Dermatosis; Rosacea; Topical therapy

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIMALARIAL AGENT; CETUXIMAB; CLINDAMYCIN; CLONIDINE; CYPROTERONE ACETATE; DOXYCYCLINE; ERLOTINIB; ERYTHROMYCIN; GEFITINIB; GLUCOCORTICOID; ISOTRETINOIN; METRONIDAZOLE; MINOCYCLINE; NADOLOL; OXYTETRACYCLINE; RETINOID; SPIRONOLACTONE; TETRACYCLINE;

CANCER CHEMOTHERAPY; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE CLASSIFICATION; HUMAN; PATHOGENESIS; REVIEW; ROSACEA;

EID: 34447282808     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Lehmann P: Rosazea. Klinik, Pathogenese, Therapie. Hautarzt 2005; 56: 871-87.
2. rd edition, 2000; 365.
3. Schöfer H: Rosazea: Klinik und aktuelle Therapie. Stuttgart, New York: Georg Thieme Verlag, 2003.
4. Berg M, Liden S: An epidemiological study of rosacea. Acta Derm Venereol 1989; 69: 419-23.
5. Brinnel H, Friedel J, Caputa M, Cabanac M, Grosshans E: Rosacea: disturbed defense against brain overheating. Arch Dermatol 1989; Res 281: 66-72.
6. Nagasaki T, Brinnel H, Hales JR, Ogawa T: Selective brain cooling in hyperthermia: the mechanisms and medical implications. Med Hypotheses 1998; 50: 203-11.
7. Wilkin JK: Rosacea: pathophysiology and treatment. Arch Dermatol 1994; 130: 359-62.
8. Crawford GH, Pelle MT, James WD: Rosacea. I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51: 327-41.
9. Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R et al.: Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 2002; 445: 584-7.
10. Lehmann P, Arens A: Rosacea fulminans. In: Dermatologie an der Schwelle zum neuen Jahrtausend (Hrsg. A. Plettenberg, W.N. Meigel, I. Moll). Berlin, Heidelberg: Springer Verlag 2000; 257-9.
11. O'Leary PA, Kierland RR: Pyoderma faciale. Arch Dermatol 1940; 41: 451-62.
12. Plewig G, Jansen T, Kligman AM: Pyoderma faciale - a review and report of 20 additional acses: Is it rosaea? Arch Dermatol 1992; 128; 1611-7.
13. Hölzle E, Jansen T, Plewig G: Morbus Morbihan - Chronisch persistierendes Ödem des Gesichtes. Hautarzt 1995; 46: 796-8.
14. Wohlrab J, Lueftl M, Marsch WC: Persistent erythema and edema of the midthird and upper aspect of the face (morbus morbihan): evidence of hidden immunologic contact urticaria and impaired lymphatic drainage. J Am Acad Dermatol 2005; 52: 595-602.
15. Jansen T, Melnik B, Plewig G: Gramnegative Follikulitis als Begleitkomplikation bei Rosazea. Akt Dermatol 1994; 20: 381-4.
16. Leyden JJ, Thew M, Kligman AM: Steroid rosacea. Arch Dermatol 1974; 111: 619-22.
17. Segaert S, van Cutsem E: Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors. Ann Oncol 2005; 16: 1425-33.
18. Gutzmer R, Werfel T, Kapp A, Elsner J: Kutane Nebenwirkungen einer EGF-Rezeptor-Blockade und deren Management. Hautarzt 2006; 57: 509-13.
19. Van Zuuren EJ, Graber MA, Hollis S, Chaudrdhry M, Gupta AK, Gover M: Interventions for rosacea. Cochrane database syst Rev 2004; (1): CD00326.
20. Lehmann P: Klinische Studien zur topischen Therapie mit Metronidazol bei Rosazea. In: Rosazea - Klinik und aktuelle Therapie. Schöfer) H (ed.), Stuttgart: Georg Thieme Verlag 2003; 41-50.
21. Altinyazar HC, Koca R, Tekin NS, Esturk E: Adapalene vs. Metronidazole gel for the treatment of rosacea. Int J Dermatol 2005; 44: 252-5.
22. Czernielewski J, Liu Y: Comparison of 15 % azelaic acid gel and 0,75 % metronidazole gel for the topical treatment of papulopustular rosacea. Arch Dermatol 2004; 140: 1282-3.
23. Bleicher PA, Charles JH, Sober AJ: Topical metronidazole therapy for rosacea. Arch Dermatol 1987; 123: 609-14.
24. Dahl MV, Katz I, Krueger GG et al.: Topical metronidazole maintains remissions of rosacea. Arch Dermatol 1998; 134: 679-83.
25. Erdoan FG, Yurtsever P, Aksoy D, Eskioglu F: Efficacy of low-dose isotretinoin in patients with treatment-resistant rosacea. Arch Dermatol 1998; 134: 884-5.